rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

500660 GLAXO Group (A)

GlaxoSmithKline Pharmaceuticals Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
28 Apr,15:58
3754.00   14.00   0.37%
Volume 728
Prev close 3,740.00
Day's H/L (Rs.) 3,785.00 - 3,705.00
52wk H/L (Rs.) 3,850.00 - 2,985.00
Mkt Cap (Rs. Cr) 31,796.38
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

GLAXO

GlaxoSmithKline Pharmaceuticals Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
28 Apr,15:53
3746.70   -22.20   -0.59%
Volume 5,557
Prev close 3768.90
Day's H/L (Rs.) 3,793.00 - 3,720.00
52wk H/L (Rs.) 3,872.00 - 2,962.35
Turnover (Rs. Lacs) 209.47
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for GlaxoSmithKline Pharmaceuticals Ltd.  (See all 755 market voices)   

140 Characters
  Cancel
Wwwhatsap-7708861772 - 5 hour(s) ago Hi. Get daily stocks updates conntact wwhtsapp
#GlaxoSmithKline-Pharmaceuticals-Ltd
Reply   |   Share
Rakesh Jhunjhunwala - 17 hour(s) ago TODAY ROCKING CALL जिनमें Invest करके कमाया जा सकता है Big मुनाफा Yahan Kare click aur jane stock k bare me with SEBI REGISTER ADVISORY contact 0977-002-1155 -- REG http://rediff.ly/2v5ks
#GlaxoSmithKline-Pharmaceuticals-Ltd
Reply   |   Share

Realtime news for GlaxoSmithKline Pharmaceuticals Ltd. (See all 126 news)

29 April 2016, 05:22
Zymeworks partners with GSK to develop bi-specific antibodies - 11 hour(s) ago
NPPA clarifies on implementation of prices fixed and notified under provisions of DPCO, 2013 - 18 Apr 2016
Global Peptic Ulcer Drugs Market to Reach US$ 40.0 Bn by 2022, With Asia Pacific Registering Highest Growth Rate, PMR Report - 11 hour(s) ago
To switch or not to switch … - 1 day(s) ago
Abdominal Aortic Aneurysm Treatment Market Analysis, Segments, Growth and Value Chain 2016-2026 - 1 day(s) ago

BSE Announcements from GlaxoSmithKline Pharmaceuticals Ltd. (See all)

Shareholding for the Period Ended March 31, 2016 - 12 Apr 2016
Board Intimation for Results & Closure of Trading Window - 28 Mar 2016

Company details for GlaxoSmithKline Pharmaceuticals Ltd.

Report Card

PE Ratios
67.11
EPS (Rs.)
55.68
Sales (Rs. Cr)
735.59
Face Value (Rs.)
10
Net Profit
Margin (%)
 
14.34
Last Bonus
1:1
Last Dividend(%)
625
Return on
Average Equity
 
25.47

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

GlaxoSmithKline Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in GlaxoSmithKline Pharmaceuticals Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare GlaxoSmithKline Pharmaceuticals Ltd. with other stocks

Ajanta Pharma Ltd.
1,478.70
Alembic Pharmaceuticals Ltd.
562.15
Show more companies
Ajanta Pharma Ltd.
1,478.70
Alembic Pharmaceuticals Ltd.
562.15
Apollo Hospitals Enterprise Ltd.
1,347.70
Aurobindo Pharma Ltd.
783.40
Biocon Ltd.
554.25
Cadila Healthcare Ltd.
320.00
Cipla Ltd.
511.75
Divi's Laboratories Ltd.
1,022.00
Dr. Reddy's Laboratories Ltd.
3,100.60
Fortis Healthcare Ltd.
180.75
Show less companies
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Portfolio
 
 
 
 
Close
Add GlaxoSmithKline Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close